Ownership rights to tissue donated for research end when the tissue leaves the body, as does all claim to benefit from commercial cell lines or other products derived from the tissue.
Specific advocate guidelines are needed for the protection of children in state custody who are potential research subjects in trials that would expose them to greater-than-minimal risk but also hold the prospect of direct benefit.
Dr Noah Boton joins Ethics Talk to discuss his article, coauthored with Dr Jeffrey Larnard: “When Should Patients at the End of Life Get Antimicrobials?”
Arguments are examined for and against the ethics of allowing U.S. armed services to attempt to recruit financially vulnerable students on medical school campuses.
The physician's duty to provide emergency treatment to combatants on both sides in an armed conflict persists, even in the context of today's asymmetrical warfare where not everyone plays by the rules.
The physician's duty to provide emergency treatment to combatants on both sides in an armed conflict persists, even in the context of today's asymmetrical warfare where not everyone plays by the rules.
Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.
The ongoing anthrax vaccination case, Doe v Rumsfeld, tests whether the military can require participation in and punish refusal of a vaccination program while waiving informed consent.